A molecular trio in relapse and remission in multiple sclerosis (Q28245076)

Nature Reviews Immunology

Europe PubMed Central

title

A molecular trio in relapse and remission in multiple sclerosis (English)

0 references

0 references

Lawrence Steinman

1

0 references

language of work or name

English

0 references

publication date

June 2009

0 references

published in

0 references

volume

9

0 references

issue

6

0 references

page(s)

440-7

0 references

cites work

Multiple sclerosis: a two-stage disease

1 reference

Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.

31 March 2020

1 reference

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

31 March 2020

1 reference

Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity

31 March 2020

1 reference

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

31 March 2020

1 reference

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

31 March 2020

1 reference

Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

31 March 2020

1 reference

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

31 March 2020

1 reference

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

31 March 2020

1 reference

Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells.

31 March 2020

1 reference

Osteopontin-induced survival of T cells

31 March 2020

1 reference

Elevated osteopontin levels in active relapsing-remitting multiple sclerosis

31 March 2020

1 reference

Plasma osteopontin levels in multiple sclerosis.

31 March 2020

1 reference

Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination

31 March 2020

1 reference

Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

31 March 2020

1 reference

The adhesion molecule and cytokine profile of multiple sclerosis lesions

31 March 2020

1 reference

Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin

31 March 2020

1 reference

Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice

31 March 2020

1 reference

Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin.

31 March 2020

1 reference

Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis

31 March 2020

1 reference

Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence

31 March 2020

1 reference

H1N1-influenza as Lazarus: genomic resurrection from the tomb of an unknown

31 March 2020

1 reference

Transformed mammalian cells secrete specific proteins and phosphoproteins

31 March 2020

1 reference

Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo

31 March 2020

1 reference

Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities

31 March 2020

1 reference

Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays

31 March 2020

1 reference

Protein co-expression with axonal injury in multiple sclerosis plaques.

31 March 2020

1 reference

Osteopontin polymorphisms and disease course in multiple sclerosis

31 March 2020

1 reference

A controlled trial of natalizumab for relapsing multiple sclerosis

31 March 2020

1 reference

T(H)-17 cells in the circle of immunity and autoimmunity

31 March 2020

1 reference

A rush to judgment on Th17

31 March 2020

1 reference

Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1.

31 March 2020

1 reference

Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules

31 March 2020

1 reference

Genealogy of the alpha-crystallin--small heat-shock protein superfamily

31 March 2020

1 reference

Crystal structure of a small heat-shock protein

31 March 2020

1 reference

The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis

31 March 2020

1 reference

31 March 2020

Assault on the guardian

1 reference

αB-Crystallin genotype has impact on the multiple sclerosis phenotype

31 March 2020

1 reference

CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation

31 March 2020

1 reference

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer

31 March 2020

1 reference

alphaB-crystallin as a marker of lymph node involvement in breast carcinoma

31 March 2020

1 reference

Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response

31 March 2020

1 reference

Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus

31 March 2020

1 reference

Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures

31 March 2020

1 reference

Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis.

31 March 2020

1 reference

Nuanced roles of cytokines in three major human brain disorders

31 March 2020

1 reference

Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19444308

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evolution and diversity of prokaryotic small heat shock proteins

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19444308